Evidence map›Paper›PMID 30762904›Full record

ArticleThe International journal of health planning and management2019

Patient costs of hypertension care in public health care facilities in Kenya.

Robinson Oyando, Martin Njoroge, Peter Nguhiu, Fredrick Kirui, Jane Mbui, Antipa Sigilai, Zipporah Bukania, Andrew Obala, Kenneth Munge, Anthony Etyang and 1 more

Abstract read
In one paragraph

Article in The International journal of health planning and management, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Robinson OyandoHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID https://orcid.org/0000-0001-8768-6014
Martin NjorogeHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Peter NguhiuHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Fredrick KiruiClinical Unit, KEMRI Centre for Clinical Research, Nairobi, Kenya.
Jane MbuiClinical Unit, KEMRI Centre for Clinical Research, Nairobi, Kenya.
Antipa SigilaiEpidemiology and Demography, KEMRI Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
Zipporah BukaniaPublic health nutrition, maternal and child health unit, KEMRI Centre for Public Health Research, Nairobi, Kenya.
Andrew ObalaMedical Microbiology and Parasitology, Moi University, Eldoret, Kenya.
Kenneth MungeHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Anthony EtyangEpidemiology and Demography, KEMRI Centre for Geographic Medicine Research, Coast, Kilifi, Kenya.
Edwine BarasaHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Funding

KEMRI Internal Research Grant KEMRI IRG-04Wellcome TrustWellcome Trust 092654Wellcome Trust 107527Wellcome Trust 214622
6 · The paper itself

Abstract

backgroundHypertension in low- and middle-income countries, including Kenya, is of economic importance due to its increasing prevalence and its potential to present an economic burden to households. In this study, we examined the patient costs associated with obtaining care for hypertension in public health care facilities in Kenya.

methodsWe conducted a cross-sectional study among adult respondents above 18 years of age, with at least 6 months of treatment in two counties. A total of 212 patients seeking hypertension care at five public facilities were interviewed, and information on care seeking and the associated costs was obtained. We computed both annual direct and indirect costs borne by these patients.

resultsOverall, the mean annual direct cost to patients was US$ 304.8 (95% CI, 235.7-374.0). Medicines (mean annual cost, US$ 168.9; 95% CI, 132.5-205.4), transport (mean annual cost, US$ 126.7; 95% CI, 77.6-175.9), and user charges (mean annual cost, US$ 57.7; 95% CI, 43.7-71.6) were the highest direct cost categories. Overall mean annual indirect cost was US$ 171.7 (95% CI, 152.8-190.5). The incidence of catastrophic health care costs was 43.3% (95% CI, 36.8-50.2) and increased to 59.0% (95% CI, 52.2-65.4) when transport costs were included.

conclusionsHypertensive patients incur substantial direct and indirect costs. High rates of catastrophic costs illustrate the urgency of improving financial risk protection for these patients and strengthening primary care to ensure affordability of hypertension care.

Indexed as

Financing, PersonalHealth ExpendituresHealth FacilitiesPublic FacilitiesCost of IllnessCross-Sectional StudiesFemaleHumansHypertensionKenyaMaleMiddle Agedcatastrophic costshypertensionKenya

Identifiers

PMID30762904
PMCPMC6618067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.